Tea Gunde

Person

Dubendorf, CH

People

Patents Grantslast 30 patents

Information Patent Grant
Hetero-dimeric multi-specific antibody format targeting at least CD...
- Patent number 12,098,203
- Issue date Sep 24, 2024
- Numab Therapeutics AG
- David Urech
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies targeting PDL1 and methods of use thereof
- Patent number 12,077,588
- Issue date Sep 3, 2024
- Numab Therapeutics AG
- Tea Gunde
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-TNF-alpha-antibodies and functional fragments thereof
- Patent number 12,043,663
- Issue date Jul 23, 2024
- TILLOTTS PHARMA AG
- Tea Gunde
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies targeting CD137 and methods of use thereof
- Patent number 11,578,133
- Issue date Feb 14, 2023
- Namab Therapeutics AG
- Tea Gunde
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Stable and soluble antibodies inhibiting TNFα
- Patent number 11,578,123
- Issue date Feb 14, 2023
- Novartis AG
- Leonardo Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-TNF-alpha-antibodies and functional fragments thereof
- Patent number 11,459,383
- Issue date Oct 4, 2022
- Tillotts Pharm AG
- Tea Gunde
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-HSA antibodies
- Patent number 11,365,240
- Issue date Jun 21, 2022
- Numab Therapeutics AG
- Tea Gunde
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD3 antibodies
- Patent number 11,319,371
- Issue date May 3, 2022
- Numab Therapeutics AG
- Tea Gunde
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-TNF-α-antibodies and functional fragments thereof
- Patent number 10,975,143
- Issue date Apr 13, 2021
- TILLOTTS PHARMA AG
- Tea Gunde
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-TNFα-antibodies and functional fragments thereof
- Patent number 10,787,508
- Issue date Sep 29, 2020
- Numab Innovation AG
- Tea Gunde
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-TNFα-antibodies and functional fragments thereof
- Patent number 10,774,140
- Issue date Sep 15, 2020
- Numab Therapeutics AG
- Tea Gunde
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-TNF-alpha-antibodies and functional fragments thereof
- Patent number 10,759,852
- Issue date Sep 1, 2020
- Numab Innovation AG
- Tea Gunde
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Stable and soluble antibodies inhibiting VEGF
- Patent number 10,590,193
- Issue date Mar 17, 2020
- Novartis AG
- Leonardo Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Stable and soluble antibodies inhibiting TNF alpha
- Patent number 10,100,111
- Issue date Oct 16, 2018
- ESBATech, an Alcon Biomedical Research Unit LLC
- Leonardo Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CD3 and IL-23 receptor binding bispecific constructs and their use...
- Patent number 10,077,312
- Issue date Sep 18, 2018
- Numab Therapeutics AG
- David Urech
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Stable and soluble antibodies inhibiting VEGF
- Patent number 9,873,737
- Issue date Jan 23, 2018
- ESBATech, an Alcon Biomedical Research Unit LLC
- Leonardo Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Stable and soluble antibodies inhibiting TNF alpha
- Patent number 9,422,366
- Issue date Aug 23, 2016
- ESBATech, an Alcon Biomedical Research Unit LLC
- Leonardo Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Stable and soluble antibodies inhibiting VEGF
- Patent number 9,090,684
- Issue date Jul 28, 2015
- Leonardo Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Stable and soluble antibodies inhibiting TNFα
- Patent number 8,673,310
- Issue date Mar 18, 2014
- ESBA Tech, an Alcon Biomedical Research Unit LLC
- Leonardo Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Stable and soluble antibodies inhibiting VEGF
- Patent number 8,349,322
- Issue date Jan 8, 2013
- ESBATech, an Alcon Biomedical Research Unit, LLC
- Leonardo Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for the identification and/or validation of receptor tyrosin...
- Patent number 7,566,528
- Issue date Jul 28, 2009
- ESBATech AG
- Tea Gunde
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODY VARIABLE DOMAINS THAT BIND IL-31
- Publication number 20240043547
- Publication date Feb 8, 2024
- Numab Therapeutics AG
- Julia TIETZ
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION TREATMENT
- Publication number 20230391882
- Publication date Dec 7, 2023
- Numab Therapeutics AG
- David URECH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-TNF-ALPHA-ANTIBODIES AND FUNCTIONAL FRAGMENTS THEREOF
- Publication number 20230279091
- Publication date Sep 7, 2023
- Tillotts Pharma AG
- Tea GUNDE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-TNF-ALPHA-ANTIBODIES AND FUNCTIONAL FRAGMENTS THEREOF
- Publication number 20230272059
- Publication date Aug 31, 2023
- Tillotts Pharma AG
- Tea GUNDE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTISPECIFIC ANTIBODY
- Publication number 20230203162
- Publication date Jun 29, 2023
- Numab Therapeutics AG
- Peter LICHTLEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC ANTIBODY
- Publication number 20230192897
- Publication date Jun 22, 2023
- Numab Therapeutics AG
- David URECH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL ANTI-CD3 ANTIBODIES
- Publication number 20220403028
- Publication date Dec 22, 2022
- Numab Therapeutics AG
- Tea GUNDE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTISPECIFIC ANTIBODIES HAVING SPECIFICITY FOR TNFA AND IL-17A, AN...
- Publication number 20220127350
- Publication date Apr 28, 2022
- Numab Therapeutics AG
- David Urech
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TARGETING CD137 AND METHODS OF USE THEREOF
- Publication number 20210395379
- Publication date Dec 23, 2021
- Numab Therapeutics AG
- Tea Gunde
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-TNF-ALPHA-ANTIBODIES AND FUNCTIONAL FRAGMENTS THEREOF
- Publication number 20210198353
- Publication date Jul 1, 2021
- Tillotts Pharma AG
- Tea GUNDE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES TARGETING CD137 AND METHODS OF USE THEREOF
- Publication number 20200332015
- Publication date Oct 22, 2020
- Numab Therapeutics AG
- Tea GUNDE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL ANTI-HSA ANTIBODIES
- Publication number 20200325214
- Publication date Oct 15, 2020
- Numab Therapeutics AG
- Tea GUNDE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-TNF-ALPHA-ANTIBODIES AND FUNCTIONAL FRAGMENTS THEREOF
- Publication number 20200299375
- Publication date Sep 24, 2020
- Tillotts Pharma AG
- Tea GUNDE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES TARGETING PDL1 AND METHODS OF USE THEREOF
- Publication number 20200283528
- Publication date Sep 10, 2020
- Numab Therapeutics AG
- Tea GUNDE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERO-DIMERIC MULTI-SPECIFIC ANTIBODY FORMAT TARGETING AT LEAST CD...
- Publication number 20200181263
- Publication date Jun 11, 2020
- Numab Therapeutics AG
- David Urech
- C07 - ORGANIC CHEMISTRY
Information Patent Application
STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF
- Publication number 20200172608
- Publication date Jun 4, 2020
- Novartis AG
- Leonardo Jose Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL ANTI-CD3 ANTIBODIES
- Publication number 20200115449
- Publication date Apr 16, 2020
- Numab Therapeutics AG
- Tea GUNDE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-TNF-ALPHA-ANTIBODIES AND FUNCTIONAL FRAGMENTS THEREOF
- Publication number 20190194310
- Publication date Jun 27, 2019
- Numab Innovation AG
- Tea GUNDE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-TNF-ALPHA-ANTIBODIES AND FUNCTIONAL FRAGMENTS THEREOF
- Publication number 20190153089
- Publication date May 23, 2019
- Numab Innovation AG
- Tea GUNDE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-TNFalpha-Antibodies and Functional Fragments Thereof
- Publication number 20190092850
- Publication date Mar 28, 2019
- NUMAB INNOVATION AG
- Tea Gunde
- C07 - ORGANIC CHEMISTRY
Information Patent Application
STABLE AND SOLUBLE ANTIBODIES INHIBITING TNF ALPHA
- Publication number 20180371074
- Publication date Dec 27, 2018
- ESBATech, an Alcon Biomedical Research Unit LLC
- Leonardo Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bispecific Constructs and Their Use in the Treatment of Various Dis...
- Publication number 20180282419
- Publication date Oct 4, 2018
- Numab Therapeutics AG
- David Urech
- C07 - ORGANIC CHEMISTRY
Information Patent Application
STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF
- Publication number 20180072802
- Publication date Mar 15, 2018
- ESBATech, an Alcon Biomedical Research Unit LLC
- Leonardo Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL MULTISPECIFIC MOLECULES AND NOVEL TREATMENT METHODS BASED ON...
- Publication number 20170073415
- Publication date Mar 16, 2017
- NUMAB AG
- David URECH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC CONSTRUCTS AND THEIR USE IN THE TREATMENT OF VARIOUS DIS...
- Publication number 20160368987
- Publication date Dec 22, 2016
- NUMAB AG
- David URECH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
STABLE AND SOLUBLE ANTIBODIES INHIBITING TNF ALPHA
- Publication number 20160251428
- Publication date Sep 1, 2016
- ESBATech, an Alcon Biomedical Research Unit LLC
- Leonardo Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL ANTIBODIES
- Publication number 20160090416
- Publication date Mar 31, 2016
- NUMAB AG
- Tea GUNDE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC CONSTRUCTS AND THEIR USE IN THE TREATMENT OF VARIOUS DIS...
- Publication number 20160083473
- Publication date Mar 24, 2016
- NUMAB AG
- David URECH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DEPLETION OF IL23R EXPRESSING CELLS IN THE TREATMENT OF VARIOUS DIS...
- Publication number 20150329637
- Publication date Nov 19, 2015
- NUMAB AG
- David URECH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF
- Publication number 20150274820
- Publication date Oct 1, 2015
- ESBATech, an Alcon Biomedical Research Unit LLC
- Leonardo Borras
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Hetero-dimeric multi-specific antibody format targeting at least CD...

Antibodies targeting PDL1 and methods of use thereof

Anti-TNF-alpha-antibodies and functional fragments thereof

Antibodies targeting CD137 and methods of use thereof

Stable and soluble antibodies inhibiting TNFα

Anti-TNF-alpha-antibodies and functional fragments thereof

Anti-HSA antibodies

Anti-CD3 antibodies

Anti-TNF-α-antibodies and functional fragments thereof

Anti-TNFα-antibodies and functional fragments thereof

Anti-TNFα-antibodies and functional fragments thereof

Anti-TNF-alpha-antibodies and functional fragments thereof

Stable and soluble antibodies inhibiting VEGF

Stable and soluble antibodies inhibiting TNF alpha

CD3 and IL-23 receptor binding bispecific constructs and their use...

Stable and soluble antibodies inhibiting VEGF

Stable and soluble antibodies inhibiting TNF alpha

Stable and soluble antibodies inhibiting VEGF

Stable and soluble antibodies inhibiting TNFα

Stable and soluble antibodies inhibiting VEGF

Method for the identification and/or validation of receptor tyrosin...

Patents Applicationslast 30 patents

ANTIBODY VARIABLE DOMAINS THAT BIND IL-31

COMBINATION TREATMENT

ANTI-TNF-ALPHA-ANTIBODIES AND FUNCTIONAL FRAGMENTS THEREOF

ANTI-TNF-ALPHA-ANTIBODIES AND FUNCTIONAL FRAGMENTS THEREOF

MULTISPECIFIC ANTIBODY

MULTISPECIFIC ANTIBODY

NOVEL ANTI-CD3 ANTIBODIES

MULTISPECIFIC ANTIBODIES HAVING SPECIFICITY FOR TNFA AND IL-17A, AN...

ANTIBODIES TARGETING CD137 AND METHODS OF USE THEREOF

ANTI-TNF-ALPHA-ANTIBODIES AND FUNCTIONAL FRAGMENTS THEREOF

ANTIBODIES TARGETING CD137 AND METHODS OF USE THEREOF

NOVEL ANTI-HSA ANTIBODIES

ANTI-TNF-ALPHA-ANTIBODIES AND FUNCTIONAL FRAGMENTS THEREOF

ANTIBODIES TARGETING PDL1 AND METHODS OF USE THEREOF

HETERO-DIMERIC MULTI-SPECIFIC ANTIBODY FORMAT TARGETING AT LEAST CD...

STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF

NOVEL ANTI-CD3 ANTIBODIES

ANTI-TNF-ALPHA-ANTIBODIES AND FUNCTIONAL FRAGMENTS THEREOF

ANTI-TNF-ALPHA-ANTIBODIES AND FUNCTIONAL FRAGMENTS THEREOF

Anti-TNFalpha-Antibodies and Functional Fragments Thereof

STABLE AND SOLUBLE ANTIBODIES INHIBITING TNF ALPHA

Bispecific Constructs and Their Use in the Treatment of Various Dis...

STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF

NOVEL MULTISPECIFIC MOLECULES AND NOVEL TREATMENT METHODS BASED ON...

BISPECIFIC CONSTRUCTS AND THEIR USE IN THE TREATMENT OF VARIOUS DIS...

STABLE AND SOLUBLE ANTIBODIES INHIBITING TNF ALPHA

NOVEL ANTIBODIES

BISPECIFIC CONSTRUCTS AND THEIR USE IN THE TREATMENT OF VARIOUS DIS...

DEPLETION OF IL23R EXPRESSING CELLS IN THE TREATMENT OF VARIOUS DIS...

STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF